(Alliance News) - Stock prices in London closed largely lower on Monday, as investors were unable to shake off concerns surrounding the conflict in the Middle East, while developments in the US bond market added to the drama. Read More
(Alliance News) - Indivior PLC forked out a bit more than expected to settle an antitrust legal case, though the agreement puts the matter to bed and provides the firm with "greater certainty". Read More
(Alliance News) - Stock prices in London opened lower on Monday, while oil and gold prices fell, as tensions in the Middle East continue to shake markets. Read More
(Alliance News) - Indivior PLC on Monday said it has reached an agreement to settle a US multi-district Suboxone litigation case, forking out USD385 million in the process. Read More
(Alliance News) - Stocks in London were lower at the close on Monday, with the FTSE 100 tipping into the red as its blue-chip housebuilders were hurt by less-than-stellar data from Rightmove and a profit warning from FTSE 250 peer Crest Nicholson. Read More
(Alliance News) - Stock prices in London were mixed at midday Monday, after a profit warning from Crest Nicholson, as well as some poor data from Rightmove, rattled stocks in the housebuilding sector. Read More
(Alliance News) - Indivior PLC on Monday announced it is resolving claims brought in antitrust multi-district litigation regarding its drug Suboxone by paying claimants millions of dollars. Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More
(Alliance News) - Indivior PLC on Thursday celebrated a strong recent six months and second quarter that brough increased profit and revenue, boosting its optimism for the rest of the year. Read More
(Alliance News) - Indivior PLC on Friday said it has reached an agreement to resolve the claims brought in antitrust multi-district litigation regarding its drug Suboxone. Read More
(Alliance News) - Indivior PLC on Tuesday said the US Food & Drug Administration has approved its OPVEE nasal spray for the emergency treatment of opioid overdose. Read More
(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Wednesday and not separately reported by Alliance News: Read More
(Alliance News) - Indivior PLC on Thursday said net revenue increased by more than 20% in the first quarter, lifting profit, and it updated its guidance for the year following its acquisition of Opiant Pharmaceuticals Inc last month. Read More
Indivior PLC - North Chesterfield, Virginia-based pharmaceutical company - Completes the acquisition of Opiant Pharmaceuticals Inc. Says the acquisition will strengthen its addiction treatment and science portfolio through the addition of Opiant's late-stage assets, notably OPNT003, an investigational opioid overdose treatment. Read More
